A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis

NCT07479615 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

498

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis
Atopic Eczema

Interventions

BIOLOGICAL: MG-K10 Humanized Monoclonal Antibody Injection

Sponsor

Shanghai Mabgeek Biotech.Co.Ltd